Cancer

Onco360® Has Been Selected as a National Specialty Pharmacy for crovalimab-akkz

LOUISVILLE, Ky., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Genentech,…

2 years ago

Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company…

2 years ago

Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine

LONG BEACH, Calif., Aug. 2, 2024 /PRNewswire/ -- Anivive Lifesciences Inc, a One Health technology company today announced that the National…

2 years ago

American Society for Transplantation and Cellular Therapy Applauds FDA Approval of TECELRA(R) for Synovial Sarcoma Treatment

CHICAGO, IL / ACCESSWIRE / August 2, 2024 / The American Society for Transplantation and Cellular Therapy (ASTCT®) applauds the…

2 years ago

KARE PharmTech Hosts Empowered Pharmacies Futures Summit to Transform Community Pharmacies

KARE PharmTech: Empowering Physicians, Pharmacists, and Patients to Improve Patient CareTAMPA, FL / ACCESSWIRE / August 2, 2024 / KARE…

2 years ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

THE WOODLANDS, TX, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical…

2 years ago

Immunovia files US patent application to protect its next-generation test

LUND, Sweden, Aug. 2, 2024 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the pancreatic cancer diagnostics company, today announces the company…

2 years ago

Chronic Prostatitis or Pelvic Pain Syndrome Treatment with Dr Allen’s Device Safely Prevents Prostate Enlargement (BPH)

Thermobalancing therapy with Dr Allen's Device treats chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) effectively and safely, helping to…

2 years ago

Hemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01

Calgary, Alberta--(Newsfile Corp. - August 1, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to…

2 years ago